Bone Biologics announces annual shareholder meeting

• Bone Biologics will hold its annual shareholder meeting in Burlington, Massachusetts on Sept. 28, 2026.
• Shareholders will vote to elect four directors.
• An advisory vote on executive compensation is scheduled, alongside ratification of Weinberg & Company as auditor for 2026.
• Ballots also cover potential share issuance tied to outstanding warrants from a private placement.
• Investors will vote on a reverse stock split within a 1-for-2 to 1-for-10 range, with authority to adjourn if needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bone Biologics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040640), on August 28, 2026, and is solely responsible for the information contained therein.